Northland Securities Estimates Astera Labs FY2026 Earnings

Astera Labs, Inc. (NASDAQ:ALAB) – Equities researchers at Northland Securities increased their FY2026 earnings per share estimates for shares of Astera Labs in a report released on Wednesday, November 4th. Northland Securities analyst G. Richard now forecasts that the company will earn $2.99 per share for the year, up from their prior estimate of $2.75. Northland Securities has an “Outperform” rating and a $315.00 price objective on the stock. The consensus estimate for Astera Labs’ current full-year earnings is $2.71 per share. Northland Securities also issued estimates for Astera Labs’ Q4 2026 earnings at $1.25 EPS, Q1 2027 earnings at $1.15 EPS, Q2 2027 earnings at $1.19 EPS, Q3 2027 earnings at $1.22 EPS, Q4 2027 earnings at $1.24 EPS and FY2027 earnings at $4.79 EPS.

A number of other research analysts have also recently commented on the company. Zacks Research cut Astera Labs from a “strong-buy” rating to a “hold” rating in a report on Monday, October 5th. Barclays lifted their price objective on shares of Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a research report on Monday, July 20th. Wall Street Zen raised shares of Astera Labs from a “hold” rating to a “buy” rating in a report on Saturday. UBS Group dropped their target price on shares of Astera Labs from $300.00 to $290.00 and set a “neutral” rating for the company in a research report on Wednesday, November 4th. Finally, Royal Bank Of Canada cut their target price on shares of Astera Labs from $500.00 to $400.00 and set an “outperform” rating for the company in a research note on Wednesday, November 4th. Thirteen research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $320.85.

Astera Labs Trading Up 13.7%

NASDAQ:ALAB opened at $216.87 on Tuesday. Astera Labs has a 12-month low of $97.89 and a 12-month high of $499.48. The stock has a 50-day moving average price of $299.01 and a 200 day moving average price of $256.00. The stock has a market capitalization of $37.62 billion, a P/E ratio of 97.93 and a beta of 3.85.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Tuesday, November 3rd. The company reported $1.32 EPS for the quarter, beating the consensus estimate of $1.19 by $0.13. The business had revenue of $584.90 million for the quarter, compared to the consensus estimate of $550.78 million. Astera Labs had a return on equity of 27.30% and a net margin of 29.64%. The business’s revenue was up 153.6% on a year-over-year basis. During the same period in the previous year, the business earned $0.49 earnings per share.

Insider Activity

In related news, COO Sanjay Gajendra sold 90,630 shares of the stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the transaction, the chief operating officer owned 1,119,038 shares of the company’s stock, valued at approximately $380,864,583.30. This trade represents a 7.49% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Jitendra Mohan sold 90,630 shares of the stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the completion of the transaction, the chief executive officer directly owned 1,266,665 shares of the company’s stock, valued at approximately $431,109,432.75. The trade was a 6.68% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last three months, insiders sold 408,558 shares of company stock worth $126,050,884. 10.40% of the stock is owned by insiders.

Institutional Investors Weigh In On Astera Labs

Several institutional investors have recently modified their holdings of ALAB. Greenleaf Trust boosted its position in shares of Astera Labs by 1.8% during the second quarter. Greenleaf Trust now owns 2,000 shares of the company’s stock worth $966,000 after purchasing an additional 36 shares in the last quarter. Parkside Financial Bank & Trust increased its position in shares of Astera Labs by 74.5% in the 2nd quarter. Parkside Financial Bank & Trust now owns 96 shares of the company’s stock valued at $46,000 after buying an additional 41 shares in the last quarter. Integrated Advisors Network LLC raised its stake in Astera Labs by 4.8% during the 3rd quarter. Integrated Advisors Network LLC now owns 983 shares of the company’s stock worth $350,000 after buying an additional 45 shares during the period. Interchange Capital Partners LLC raised its stake in Astera Labs by 4.4% during the 3rd quarter. Interchange Capital Partners LLC now owns 1,187 shares of the company’s stock worth $423,000 after buying an additional 50 shares during the period. Finally, Glenmede Trust Co. NA raised its stake in Astera Labs by 2.7% during the 1st quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock worth $209,000 after buying an additional 51 shares during the period. 60.47% of the stock is owned by institutional investors.

Key Stories Impacting Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Shares rallied alongside a broader tech-stock surge, providing a near-term market tailwind after a sharp recent pullback. Astera Labs rallies 14% on tech stock surge
• Positive Sentiment: Strong business momentum may support investor confidence: third-quarter revenue was about $585 million, and fourth-quarter revenue guidance had a midpoint of $740 million. An analyst upgrade highlighted rising revenue per accelerator as customers adopt higher-value Scorpio switches, alongside opportunities in optical and rack-level solutions. Astera Labs Is Increasing Their Revenue Per Accelerator
• Neutral Sentiment: The rebound follows a reported 26% five-session decline despite strong earnings and guidance. Competing semiconductor companies also reported robust data-center growth, underscoring strong sector demand but keeping the competitive backdrop in focus. Astera Labs Stock Drops 26% in a Week Despite Strong Earnings
• Negative Sentiment: Director Stefan Dyckerhoff reported selling shares in two transactions at an average price of $211.41. The sales were made under a pre-arranged Rule 10b5-1 plan, which may temper their significance as a signal of his outlook. SEC Form 4 filing

About Astera Labs

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help move data among processors, accelerators, memory and other components in high-performance computing systems.

The company’s portfolio includes Aries PCIe and CXL retimers, Taurus Ethernet smart cable modules, Scorpio fabric switches and Leo CXL memory connectivity controllers. Astera Labs also offers software tools to help customers configure and monitor its connectivity products.

Founded in 2017 and headquartered in Santa Clara, California, Astera Labs serves the global cloud and computing markets.